In trading today, Marvel Biosciences Corp shares closed at $0.14 after opening the day at $0.15. It traded at a low of $0.14 to a high of $0.15.

Shares dipped -3.33 percent from the previous day's close of $0.15.

Today across North America, the TSX Composite closed 1.42% at 22259.47, the S&P 500 closed 1.03% at 5180.74, the Dow Jones Industrial Average closed 0.46% at 38852.27 and the Nasdaq Composite closed 1.19% at 16349.25.

Marvel Biosciences Corp traded under MRVL on the Toronto Venture Exchange (TSX-V).

Trading volume was 18,500 on 6 total trades. On average, Marvel Biosciences Corp has traded 42,300 shares in the last five days and 47,111 year-to-date.

Trading across the entire TSX-V saw 2,888 price advancers against 2,298 declines and 125 unchanged.

During the prior 52 weeks, MRVL.VN has traded as high as $0.19 (February 07,2024) and low as $0.01 (October 02,2023). Moreover, the shares have boosted 45.00 percent in the last 12 months, while they have soared 81.25% since the start of 2024.

Following today's trading, Marvel Biosciences Corp has a market capitalization of $5.97 million on a float of 39,786 shares outstanding. Its annual EPS is $-0.07.

Marvel Biosciences Corp is a TSX Biotechnology company headquartered in Calgary, CAN.

Currently, Marvel Biosciences Corp's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..